Author:
Wang Hailun,Miles Brett A.
Reference37 articles.
1. Anbari KK, et al. Melanoma of unknown primary site: presentation, treatment and prognosis—a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer. 1997;79(9):1816–21.
2. Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, Owens M, Stampone P, Gollnick H. Recurrence rate of suprficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol. 2005;15:374–81.
3. Berner A. Actinic keratosis and development of squamous cell carcinoma of the skin. J Norwegian Med Assoc. 2005;125:1653–4.
4. Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011;65(5):1032–47.
5. Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R, Cormier JN, Xing Y. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma: a meta-analysis. J Natl Cancer Inst. 2011;103(2):129–42.